Decreto Supremo 016-2011-SA: Peru Registro Sanitario Regulation Explained

Regulatory information verified as of October 29, 2026.

1. Key takeaways

D.S. N° 016-2011-SA, published on 2011-07-27, is the operating system for sanitary registration, control and vigilance in Peru: the dossier composition for Class I and Class II devices, the assessment timelines and the change rules are all written into it. For the verified Class A registration record, the amendments dedicated to this regulation number 4: D.S. N° 001-2012-SA (2012-01-22), D.S. N° 016-2013-SA (2013-12-24), D.S. N° 029-2015-SA (2015-09-12) and D.S. N° 016-2017-SA (2017-06-07). Industry commentary sometimes counts R.M. N° 966-2019/MINSA, published on 2019-10-16, as a fifth amendment, but the verified target of that instrument is D.S. N° 014-2011-SA, the regulation on pharmaceutical establishments, not 016-2011-SA itself; this distinction is controlled by official publication. When citing the regulation, companies must always carry the amending version, otherwise the text they rely on may be an old provision that has already been replaced.

2. Legal basis

Regulatory information verified as of October 29, 2026.

3. Expert insights

Insight 1: The 2017 amendment aligned terminology first and delivered the checklist later.

D.S. N° 016-2017-SA, published on 2017-06-07, replaced condiciones esenciales with principios esenciales throughout Title IV, while substantially amending Art. 12, 18, 26, 31, 40, 60, 62, 70, 81, 93, 94, 95, 104, 115, 124, 125, 127, 130 and other provisions. The action itself did not immediately increase the documentary burden, but it aligned terminology three years ahead of D.S. N° 003-2020-SA, published on 2020-02-06, which established the essential principles checklist. The mechanical implication is that Peru upgrades its technical requirements by unifying terminology first and landing the checklist second: a dossier written on the old terminology will be rejected in post-2020 review as non-conforming. Seen from the other side, the amendment also shows that the dossier articles (Art. 124 and Art. 125) are repeatedly adjusted targets, so reusing old dossier checklists circulating on the internet carries a higher risk than reusing any other chapter.

Insight 2: Two parallel review-clock units exist and must not be mixed.

Art. 136 of the regulation sets statutory calendar-day ceilings: Class I 30, Class II 60, and Classes III and IV 90 calendar days. The current consolidated procedures text, D.S. N° 011-2026-SA published on 2026-07-21, instead sets working-day clocks: Class I 22, Class II 44, and Classes III and IV 66 working days, with in vitro diagnostic devices at 30 working days (practical estimate; article numbers not verified line by line). The units differ and so do the start rules, so scheduling should manage progress on the working-day clock while judging statutory overrun against the calendar-day ceiling. Using either one alone produces wrong conclusions about whether a review has gone overdue.

Insight 3: Changes are split into two tiers, and the deciding point is whether technical content is touched.

Sección 1.3 handles layout-only cases (layout changes), Art. 138 and Art. 140 handle substantive changes requiring assessment, and Sección 1.5 handles contractual and staged-production arrangements. This split determines the change schedule: map the intended change to Sección 1.3 or to Art. 138/Art. 140 first, and only then decide whether to process it as a change on the existing sanitary registration or to file a new one. Misclassifying the change leads either to rejection of the filing or to a demand that the full assessment be repeated from the beginning.

4. Practical recommendations

1. Always cite provisions with the amending version: write D.S. N° 016-2011-SA (as amended by D.S. N° 016-2017-SA), Art. 124, to avoid citing replaced text. Attach inside the dossier a one-page version concordance table listing the current version and publication date of every provision cited in the report, for the reviewer to verify.
2. Run a dual-clock schedule log: a working-day column for progress management and a calendar-day column for statutory overrun and remedy triggers; never merge the two columns after converting between them.
3. Classify the change before filing: apply the boundary between Sección 1.3 and Art. 138 and Art. 140, and issue a written classification opinion before choosing the path.
4. Route staged production and contractual arrangements through Sección 1.5: where multiple manufacturing sites are involved, explain the contractual relationships and division of responsibilities in the dossier in one pass.
5. Manage in vitro diagnostic devices on a separate track: under the first supplementary transitional provision of D.S. N° 001-2012-SA, IVDs follow the D.S. N° 010-97-SA (published 1997-12-23) channel, are not mixed into Classes I-IV, and do not use the dossier articles of this regulation.
6. Design transfers under Art. 8: a sanitary registration may only be transferred by the holder to another qualified entity; settle the contract first and then run the administrative procedure, never in reverse order.

5. Verification checklist

□ Confirmed that the core regulation is D.S. N° 016-2011-SA (published 2011-07-27)

□ Confirmed that the dedicated amendments number 4, each cited with its publication date

□ Confirmed that R.M. N° 966-2019/MINSA (2019-10-16) amends D.S. N° 014-2011-SA and is not counted in the 016-2011-SA amendment sequence

□ Distinguished the Art. 136 calendar-day ceilings (30 / 60 / 90) from the TUPA working-day clocks (22 / 44 / 66)

□ Completed the change classification against Sección 1.3, Sección 1.5 and Art. 138 and Art. 140

□ Confirmed that in vitro diagnostic devices follow the parallel D.S. N° 010-97-SA channel

□ Confirmed that transfer arrangements comply with the Art. 8 restriction that only the holder may transfer to another qualified entity

□ Attached to the dossier a concordance table of current versions for all cited provisions

Regulatory information verified as of October 29, 2026.

GRZAN Regulatory Team

GRZAN provides medical device registration support in Peru for manufacturers, importers and authorized representatives. For inquiries, contact info@grzanglobal.com.